Skip to main content
Have a personal or library account? Click to login
Crystal modifications and dissolution rate of piroxicam Cover

Crystal modifications and dissolution rate of piroxicam

Open Access
|Dec 2011

References

  1. A. Rajendarn and S. K. Basu, Crystal modification of dipyridamole using different solvents and crystallization conditions,(2006) 27-34; DOI: 10.1016/J.IJPHARM.2006.04.021.
  2. N. Blagden, M. de Matas, P. T. Gavan and P. York, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates,(2007) 617-630; DOI: 10.1016/J.ADDR.2007.05.011.
  3. S. R. Byrn, R. R. Pfeiffer, G. Stephenson, D. J. W. Grant and W. B. Gleason, Solid state pharmaceutical chemistry,(1994) 1148; DOI: 10.1021/cm00044a013.
  4. M. El-Baldry, G. Fetih and M. Fathy, Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG 4000,(2009) 219-229; DOI: 10.1016/J.JSPS.2009.08.006.
  5. M. Fernandez, I. C. Rodriguez and A. Crezo, Characterization of solid dispersions of piroxicam/polyethylene glycol 4000,(1992) 197-202; DOI: 10.1016/0378-5173(92)90060-F.
  6. D. Horter and J. B. Dressman, Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract,(1997) 3-14; DOI: 10.1016/S0169-409X (00) 00130-7.
  7. P. B. Myrdal and M. J. Jozwiakowski,, 2ed. (Ed. R. Lin), AustarPharma, Edison (NJ), 2008.
  8. M. C. Martinez-Oharriz, C. Martýn, M. M. Goni, C. Rodrýguez-Espinosa, A. Zornoza and M. C. Tros-Ilarduya, Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal,(1999) 127-132; DOI: 10.1016/S0928-0987(99)00006-8.
  9. M. Mihalić, H. Hofman, J. Kuftinec, B. Krile, M. Zinic, F. Kajfez and N. Blazevic, Physicochemical and analytical characteristics of piroxicam,(1982) 13-20.
  10. K. Srinivasan, K. Sankaranarayanan, S. Thangavelu and P. Ramasamy, Influence of organic solvents on the habit of NMBA (4-nitro-4'-methyl benzylidene aniline) crystals,(2000) 246-54; DOI: 10.1016/S0022-0248(00)00300-6.
  11. V. Tantishaiyakul, N. Kaewnopparat and S. Ingkatawornwong, Properties of solid dispersion of piroxicam in polyvinylpyrrodine,(1999) 143-51; DOI: 10.1016/S0378-5173(96)04687-X.
  12. S. Verheyen, N. Blaton, R. Kinget and G. Van den Mooter, Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions,(2002) 45-58; DOI: 10.1016/S0378-5173(02)00532-X.
  13. F. Vrecer and S. Srcic, Investigation of piroxicam polymorphism,(1990) 35-41; DOI: 10.1016/S0378-5173(03)00057-7.
  14. F. Vrečer, M. Vrbinc and A. Meden, Characterisation of piroxicam crystal modifications,(2003) 3-15; DOI: 10.1016/S0378-5173(03)00057-7.
  15. , USP Pharmacopoeial Convention, Rockville (MD) 2000.
DOI: https://doi.org/10.2478/v10007-011-0037-z | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 391 - 402
Published on: Dec 25, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2011 Lim Lyn, Huan Sze, Adhiyaman Rajendran, Gorajana Adinarayana, Kamal Dua, Sanjay Garg, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.